elvanse 20mg capsules
takeda uk ltd - lisdexamfetamine dimesylate - oral capsule - 20mg
elvanse 40mg capsules
takeda uk ltd - lisdexamfetamine dimesylate - oral capsule - 40mg
elvanse 60mg capsules
takeda uk ltd - lisdexamfetamine dimesylate - oral capsule - 60mg
vyvanse tablet (chewable)
takeda canada inc - lisdexamfetamine dimesylate - tablet (chewable) - 10mg - lisdexamfetamine dimesylate 10mg - amphetamines
vyvanse tablet (chewable)
takeda canada inc - lisdexamfetamine dimesylate - tablet (chewable) - 20mg - lisdexamfetamine dimesylate 20mg - amphetamines
vyvanse tablet (chewable)
takeda canada inc - lisdexamfetamine dimesylate - tablet (chewable) - 30mg - lisdexamfetamine dimesylate 30mg - amphetamines
vyvanse tablet (chewable)
takeda canada inc - lisdexamfetamine dimesylate - tablet (chewable) - 40mg - lisdexamfetamine dimesylate 40mg - amphetamines
vyvanse tablet (chewable)
takeda canada inc - lisdexamfetamine dimesylate - tablet (chewable) - 50mg - lisdexamfetamine dimesylate 50mg - amphetamines
vyvanse tablet (chewable)
takeda canada inc - lisdexamfetamine dimesylate - tablet (chewable) - 60mg - lisdexamfetamine dimesylate 60mg - amphetamines
vyvanse 30 mg
medison pharma ltd - lisdexamfetamine dimesylate - capsules - lisdexamfetamine dimesylate 30 mg - lisdexamfetamine - vyvanse is a central nervous system (cns) stimulant indicated for the treatment of attention deficit hyperactivity disorder (adhd) in patients ages 6 years and above.vyvanse is indicated for the treatment of moderate to severe binge eating disorder (bed) for patient over 18 years.limitation of use:vyvanse is not indicated or recommended for weight loss. use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. the safety and effectiveness of vyvanse for the treatment of obesity have not been established